Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis

Table 1 Key indicators for (MDR) TB incidence and the MDR-TB treatment program of the NTP in four Sub-Saharan African countries

Country	TB incidence per 100,000 population (2017) [16]	MDR-TB incidence per 100,000 population (2017) [16]	Number of MDR-TB treatment centers (2018)	Number of MDR-TB patients (period) [16]	Number of MDR-TB patients receiving NDR (period)
Eswatini	308	31	13	702 (2018)	276 (2018)
Ethiopia	164	5.2	50	716 (2018)	110 (2018)
Nigeria	219	12	28	1786 (2017) [16]	33 (2017)
Tanzania	269	2.9	75	145 (2018)	129 (Nov 2017-Jul 2018)

The MDR-TB treatment centers usually initiate DR-TB treatment; once patients are stable on treatment, they are referred to satellite centers in all countries (except for Eswatini) to complete their treatment. In Ethiopia and Tanzania, patients have to visit the satellite center daily to receive treatment, while community-based treatment occurs in Eswatini and Nigeria. During their treatment, monthly checkup visits are scheduled at a DR-TB treatment center (Eswatini, Ethiopia, and Tanzania) or in a satellite center (Nigeria) in which specimens are collected to assess treatment response and other laboratory tests may be performed to check for adverse events

ISSN: 1472-6963